EDITAS MEDICINE, INC. Comprehensive Income
EDITAS MEDICINE, INC. (EDIT) reported Comprehensive Income of -$18.24 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-05
- EDITAS MEDICINE, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$18.24M.
- EDITAS MEDICINE, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$24.98M.
- EDITAS MEDICINE, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$5.62M.
- EDITAS MEDICINE, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$25.13M.
- EDITAS MEDICINE, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$160.33M.
- EDITAS MEDICINE, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$237.02M.
- EDITAS MEDICINE, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$149.42M.
- EDITAS MEDICINE, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$223.54M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$18.24M 10-Q · filed 2026-08-05 | -$43.22M 10-Q · filed 2026-08-05 | -$48.84M derived: sum of 3 quarters · filed 2026-08-05 | -$73.97M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | -$24.98M 10-Q · filed 2026-05-05 | -$30.60M derived: sum of 2 quarters · filed 2026-05-05 | -$55.73M derived: sum of 3 quarters · filed 2026-05-05 | -$109.04M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | -$5.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$30.75M derived: sum of 2 quarters · filed 2026-03-09 | -$84.06M derived: sum of 3 quarters · filed 2026-08-05 | -$160.33M 10-K · filed 2026-03-09 | |
| 2025-09-30 | -$25.13M 10-Q · filed 2025-11-10 | -$78.44M derived: sum of 2 quarters · filed 2026-08-05 | -$154.71M 10-Q · filed 2025-11-10 | -$200.36M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | -$53.31M 10-Q · filed 2026-08-05 | -$129.58M 10-Q · filed 2026-08-05 | -$175.22M derived: sum of 3 quarters · filed 2026-08-05 | -$236.40M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | -$76.27M 10-Q · filed 2026-05-05 | -$121.92M derived: sum of 2 quarters · filed 2026-05-05 | -$183.09M derived: sum of 3 quarters · filed 2026-05-05 | -$250.82M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | -$45.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$106.83M derived: sum of 2 quarters · filed 2026-03-09 | -$174.55M derived: sum of 3 quarters · filed 2026-03-09 | -$237.02M 10-K · filed 2026-03-09 | |
| 2024-09-30 | -$61.18M 10-Q · filed 2025-11-10 | -$128.90M derived: sum of 2 quarters · filed 2025-11-10 | -$191.37M 10-Q · filed 2025-11-10 | -$208.60M derived: sum of 4 quarters · filed 2025-11-10 | |
| 2024-06-30 | -$67.72M 10-Q · filed 2025-08-12 | -$130.20M 10-Q · filed 2025-08-12 | -$147.42M derived: sum of 3 quarters · filed 2025-08-12 | -$191.61M derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | -$62.47M 10-Q · filed 2025-05-12 | -$79.70M derived: sum of 2 quarters · filed 2025-05-12 | -$123.88M derived: sum of 3 quarters · filed 2025-05-12 | -$164.18M derived: sum of 4 quarters · filed 2025-05-12 | |
| 2023-12-31 | -$17.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | -$61.41M derived: sum of 2 quarters · filed 2025-03-05 | -$101.71M derived: sum of 3 quarters · filed 2025-03-05 | -$149.42M 10-K · filed 2025-03-05 | |
| 2023-09-30 | -$44.19M 10-Q · filed 2024-11-04 | -$84.48M derived: sum of 2 quarters · filed 2024-11-04 | -$132.20M 10-Q · filed 2024-11-04 | -$192.24M derived: sum of 4 quarters · filed 2025-03-05 | |
| 2023-06-30 | -$40.30M 10-Q · filed 2024-08-07 | -$88.01M 10-Q · filed 2024-08-07 | -$148.06M derived: sum of 3 quarters · filed 2025-03-05 | -$204.69M derived: sum of 4 quarters · filed 2025-03-05 | |
| 2023-03-31 | -$47.71M 10-Q · filed 2024-05-08 | -$107.76M derived: sum of 2 quarters · filed 2025-03-05 | -$164.39M derived: sum of 3 quarters · filed 2025-03-05 | -$218.72M derived: sum of 4 quarters · filed 2025-03-05 | |
| 2022-12-31 | -$60.05M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | -$116.68M derived: sum of 2 quarters · filed 2025-03-05 | -$171.01M derived: sum of 3 quarters · filed 2025-03-05 | -$223.54M 10-K · filed 2025-03-05 | |
| 2022-09-30 | -$56.63M 10-Q · filed 2023-11-03 | -$110.96M derived: sum of 2 quarters · filed 2023-11-03 | -$163.49M 10-Q · filed 2023-11-03 | -$205.36M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | -$54.33M 10-Q · filed 2023-08-02 | -$106.86M 10-Q · filed 2023-08-02 | -$148.73M derived: sum of 3 quarters · filed 2024-02-28 | -$187.80M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | -$52.53M 10-Q · filed 2023-05-05 | -$94.40M derived: sum of 2 quarters · filed 2024-02-28 | -$133.47M derived: sum of 3 quarters · filed 2024-02-28 | -$188.72M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | -$41.87M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$80.94M derived: sum of 2 quarters · filed 2024-02-28 | -$136.19M derived: sum of 3 quarters · filed 2024-02-28 | -$192.95M 10-K · filed 2024-02-28 | |
| 2021-09-30 | -$39.08M 10-Q · filed 2022-11-02 | -$94.33M derived: sum of 2 quarters · filed 2022-11-02 | -$151.08M 10-Q · filed 2022-11-02 | -$213.58M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-06-30 | -$55.25M 10-Q · filed 2022-08-03 | -$112.01M 10-Q · filed 2022-08-03 | -$174.51M derived: sum of 3 quarters · filed 2023-02-22 | -$166.92M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-03-31 | -$56.76M 10-Q · filed 2022-05-04 | -$119.25M derived: sum of 2 quarters · filed 2023-02-22 | -$111.66M derived: sum of 3 quarters · filed 2023-02-22 | -$135.75M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2020-12-31 | -$62.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$54.91M derived: sum of 2 quarters · filed 2023-02-22 | -$78.99M derived: sum of 3 quarters · filed 2023-02-22 | -$116.13M 10-K · filed 2023-02-22 | |
| 2020-09-30 | $7.59M 10-Q · filed 2021-11-09 | -$16.50M derived: sum of 2 quarters · filed 2021-11-09 | -$53.63M 10-Q · filed 2021-11-09 | -$91.33M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | -$24.08M 10-Q · filed 2021-08-05 | -$61.22M 10-Q · filed 2021-08-05 | -$98.92M derived: sum of 3 quarters · filed 2022-02-24 | -$131.87M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | -$37.14M 10-Q · filed 2021-05-06 | -$74.84M derived: sum of 2 quarters · filed 2022-02-24 | -$107.79M derived: sum of 3 quarters · filed 2022-02-24 | -$141.56M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | -$37.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$70.65M derived: sum of 2 quarters · filed 2022-02-24 | -$104.42M derived: sum of 3 quarters · filed 2022-02-24 | -$133.61M 10-K · filed 2022-02-24 | |
| 2019-09-30 | -$32.95M 10-Q · filed 2020-11-06 | -$66.72M derived: sum of 2 quarters · filed 2020-11-06 | -$95.91M 10-Q · filed 2020-11-06 | -$120.91M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-06-30 | -$33.77M 10-Q · filed 2020-08-07 | -$62.96M 10-Q · filed 2020-08-07 | -$87.96M derived: sum of 3 quarters · filed 2021-02-26 | -$103.28M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-03-31 | -$29.19M 10-Q · filed 2020-05-08 | -$54.19M derived: sum of 2 quarters · filed 2021-02-26 | -$69.51M derived: sum of 3 quarters · filed 2021-02-26 | -$108.18M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2018-12-31 | -$25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$40.32M derived: sum of 2 quarters · filed 2021-02-26 | -$78.99M derived: sum of 3 quarters · filed 2021-02-26 | -$109.91M 10-K · filed 2021-02-26 | |
| 2018-09-30 | -$15.32M 10-Q · filed 2019-11-12 | -$53.99M derived: sum of 2 quarters · filed 2019-11-12 | -$84.91M 10-Q · filed 2019-11-12 | -$121.15M derived: sum of 4 quarters · filed 2020-02-26 | |
| 2018-06-30 | -$38.67M 10-Q · filed 2019-08-07 | -$38.67M 10-Q · filed 2018-08-07 | -$69.58M 10-Q · filed 2019-08-07 | -$105.83M derived: sum of 3 quarters · filed 2020-02-26 | -$132.38M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | -$30.91M 10-Q · filed 2019-05-08 | -$30.99M 10-Q · filed 2018-05-04 | -$67.16M derived: sum of 2 quarters · filed 2020-02-26 | -$93.71M derived: sum of 3 quarters · filed 2020-02-26 | -$120.22M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | -$36.24M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$62.80M derived: sum of 2 quarters · filed 2020-02-26 | -$89.30M derived: sum of 3 quarters · filed 2020-02-26 | -$120.40M 10-K · filed 2020-02-26 | |
| 2017-09-30 | -$26.55M 10-Q · filed 2018-11-08 | -$53.06M derived: sum of 2 quarters · filed 2018-11-08 | -$84.16M 10-Q · filed 2018-11-08 | -$123.53M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-06-30 | -$26.51M 10-Q · filed 2018-08-07 | -$57.60M 10-Q · filed 2018-08-07 | -$96.98M derived: sum of 3 quarters · filed 2019-03-01 | -$118.00M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-03-31 | -$31.10M 10-Q · filed 2018-05-04 | -$70.47M derived: sum of 2 quarters · filed 2019-03-01 | -$91.49M derived: sum of 3 quarters · filed 2019-03-01 | -$110.53M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2016-12-31 | -$39.38M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$60.40M derived: sum of 2 quarters · filed 2019-03-01 | -$79.44M derived: sum of 3 quarters · filed 2019-03-01 | -$97.18M 10-K · filed 2019-03-01 | |
| 2016-09-30 | -$21.02M 10-Q · filed 2017-11-08 | -$40.06M derived: sum of 2 quarters · filed 2017-11-08 | -$57.81M 10-Q · filed 2017-11-08 | ||
| 2016-06-30 | -$19.04M 10-Q · filed 2017-08-09 | -$36.79M 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | -$72.90M 10-K · filed 2018-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |